Eleven Biotherapeutics (EBIO) To Participate In Upcoming Investor Conferences In September
8/29/2014 11:59:43 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics (NASDAQ: EBIO), a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Abbie Celniker, Ph.D., President and Chief Executive Officer, will participate in the following upcoming investor conferences in September:
Help employers find you! Check out all the jobs and post your resume.
comments powered by